CA2385300A1 - A method for treating biofilm and other slime products with endo-beta-1,2-galactanase - Google Patents

A method for treating biofilm and other slime products with endo-beta-1,2-galactanase Download PDF

Info

Publication number: CA2385300A1
Authority: CA; Canada
Prior art keywords: enzyme; beta; galactanase; endo; polysaccharide
Prior art date: 1999-09-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002385300A

Other languages

English (en)

French (fr)

Inventor

Marjaana Ratto

Matti Siika-Aho

Tarmo Pellikka

Reetta Piskonen

Anita Teleman

Satu Salo

Liisa Viikari

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

VTT Technical Research Centre of Finland Ltd

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-29

Filing date

2000-09-29

Publication date

2001-04-05

2000-09-29 Application filed by Individual filed Critical Individual

2001-04-05 Publication of CA2385300A1 publication Critical patent/CA2385300A1/en

Status Abandoned legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 67
102000004190 Enzymes Human genes 0.000 claims abstract description 200
108090000790 Enzymes Proteins 0.000 claims abstract description 200
239000005017 polysaccharide Substances 0.000 claims abstract description 172
229920001282 polysaccharide Polymers 0.000 claims abstract description 153
238000002360 preparation method Methods 0.000 claims abstract description 45
150000004676 glycans Chemical class 0.000 claims abstract description 31
150000002772 monosaccharides Chemical class 0.000 claims abstract description 28
230000000593 degrading effect Effects 0.000 claims abstract description 16
150000002482 oligosaccharides Chemical class 0.000 claims abstract description 13
229920001542 oligosaccharide Polymers 0.000 claims abstract description 11
230000008569 process Effects 0.000 claims abstract description 11
229940088598 enzyme Drugs 0.000 claims description 198
150000004804 polysaccharides Polymers 0.000 claims description 158
229930182830 galactose Natural products 0.000 claims description 27
IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims description 26
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 claims description 18
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 17
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical group OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 17
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 17
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 17
238000011282 treatment Methods 0.000 claims description 17
SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 16
239000008103 glucose Substances 0.000 claims description 16
235000001727 glucose Nutrition 0.000 claims description 16
230000000813 microbial effect Effects 0.000 claims description 16
239000000126 substance Substances 0.000 claims description 14
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 13
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 10
SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 9
SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims description 9
PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims description 9
PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 9
239000003139 biocide Substances 0.000 claims description 9
239000000872 buffer Substances 0.000 claims description 9
AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 claims description 8
229940097043 glucuronic acid Drugs 0.000 claims description 8
108091005804 Peptidases Proteins 0.000 claims description 6
239000004365 Protease Substances 0.000 claims description 6
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 6
239000000654 additive Substances 0.000 claims description 6
108010005131 levanase Proteins 0.000 claims description 6
230000003115 biocidal effect Effects 0.000 claims description 5
-1 .beta.-glucanase Proteins 0.000 claims description 4
KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 claims description 4
108010002430 hemicellulase Proteins 0.000 claims description 4
229940059442 hemicellulase Drugs 0.000 claims description 4
102100032487 Beta-mannosidase Human genes 0.000 claims description 3
108010022172 Chitinases Proteins 0.000 claims description 3
102000012286 Chitinases Human genes 0.000 claims description 3
108090001060 Lipase Proteins 0.000 claims description 3
102000004882 Lipase Human genes 0.000 claims description 3
239000004367 Lipase Substances 0.000 claims description 3
108010014251 Muramidase Proteins 0.000 claims description 3
102000016943 Muramidase Human genes 0.000 claims description 3
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 3
108010059820 Polygalacturonase Proteins 0.000 claims description 3
229920001131 Pulp (paper) Polymers 0.000 claims description 3
108010055059 beta-Mannosidase Proteins 0.000 claims description 3
239000002270 dispersing agent Substances 0.000 claims description 3
108010093305 exopolygalacturonase Proteins 0.000 claims description 3
235000019421 lipase Nutrition 0.000 claims description 3
229960000274 lysozyme Drugs 0.000 claims description 3
239000004325 lysozyme Substances 0.000 claims description 3
235000010335 lysozyme Nutrition 0.000 claims description 3
239000003381 stabilizer Substances 0.000 claims description 3
PIEXCQIOSMOEOU-UHFFFAOYSA-N 1-bromo-3-chloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Br)C(=O)N(Cl)C1=O PIEXCQIOSMOEOU-UHFFFAOYSA-N 0.000 claims description 2
UUIVKBHZENILKB-UHFFFAOYSA-N 2,2-dibromo-2-cyanoacetamide Chemical compound NC(=O)C(Br)(Br)C#N UUIVKBHZENILKB-UHFFFAOYSA-N 0.000 claims description 2
XDMYYHWZRFUZSZ-UHFFFAOYSA-N 4-chloro-2-methyl-1,2-thiazolidin-3-one Chemical compound CN1SCC(Cl)C1=O XDMYYHWZRFUZSZ-UHFFFAOYSA-N 0.000 claims description 2
LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 claims description 2
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 2
239000004480 active ingredient Substances 0.000 claims description 2
PQRDTUFVDILINV-UHFFFAOYSA-N bcdmh Chemical compound CC1(C)N(Cl)C(=O)N(Br)C1=O PQRDTUFVDILINV-UHFFFAOYSA-N 0.000 claims description 2
229960003168 bronopol Drugs 0.000 claims description 2
FAOSYNUKPVJLNZ-UHFFFAOYSA-N butylstannane Chemical compound CCCC[SnH3] FAOSYNUKPVJLNZ-UHFFFAOYSA-N 0.000 claims description 2
SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims description 2
229960001031 glucose Drugs 0.000 claims 3
DDPJJWIKEDDECP-UHFFFAOYSA-N 4-methyl-1,2-thiazolidin-3-one Chemical compound CC1CSNC1=O DDPJJWIKEDDECP-UHFFFAOYSA-N 0.000 claims 1
239000005644 Dazomet Substances 0.000 claims 1
QAYICIQNSGETAS-UHFFFAOYSA-N dazomet Chemical compound CN1CSC(=S)N(C)C1 QAYICIQNSGETAS-UHFFFAOYSA-N 0.000 claims 1
229940041290 mannose Drugs 0.000 claims 1
230000000694 effects Effects 0.000 abstract description 44
238000001035 drying Methods 0.000 abstract description 2
239000000243 solution Substances 0.000 description 34
239000001963 growth medium Substances 0.000 description 29
239000002609 medium Substances 0.000 description 23
241000588747 Klebsiella pneumoniae Species 0.000 description 19
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
235000015097 nutrients Nutrition 0.000 description 18
239000002361 compost Substances 0.000 description 17
238000004519 manufacturing process Methods 0.000 description 17
229940045505 klebsiella pneumoniae Drugs 0.000 description 16
108090000623 proteins and genes Proteins 0.000 description 16
238000000746 purification Methods 0.000 description 16
150000001720 carbohydrates Chemical class 0.000 description 15
238000012216 screening Methods 0.000 description 15
239000002689 soil Substances 0.000 description 15
238000012360 testing method Methods 0.000 description 15
241000894006 Bacteria Species 0.000 description 14
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 14
230000015572 biosynthetic process Effects 0.000 description 14
229910052799 carbon Inorganic materials 0.000 description 14
238000005755 formation reaction Methods 0.000 description 14
239000000523 sample Substances 0.000 description 14
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 13
235000018102 proteins Nutrition 0.000 description 13
102000004169 proteins and genes Human genes 0.000 description 13
239000008363 phosphate buffer Substances 0.000 description 12
230000001580 bacterial effect Effects 0.000 description 11
230000003247 decreasing effect Effects 0.000 description 11
235000014633 carbohydrates Nutrition 0.000 description 10
239000000203 mixture Substances 0.000 description 10
230000003301 hydrolyzing effect Effects 0.000 description 9
238000005349 anion exchange Methods 0.000 description 8
238000002523 gelfiltration Methods 0.000 description 8
230000007062 hydrolysis Effects 0.000 description 7
238000006460 hydrolysis reaction Methods 0.000 description 7
AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 description 7
235000000346 sugar Nutrition 0.000 description 7
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
229930091371 Fructose Natural products 0.000 description 6
239000005715 Fructose Substances 0.000 description 6
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 6
229910019142 PO4 Inorganic materials 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
238000007792 addition Methods 0.000 description 6
238000005119 centrifugation Methods 0.000 description 6
238000002474 experimental method Methods 0.000 description 6
238000002955 isolation Methods 0.000 description 6
244000005700 microbiome Species 0.000 description 6
235000021317 phosphate Nutrition 0.000 description 6
239000011347 resin Substances 0.000 description 6
229920005989 resin Polymers 0.000 description 6
239000000758 substrate Substances 0.000 description 6
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
229930006000 Sucrose Natural products 0.000 description 5
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
239000002253 acid Substances 0.000 description 5
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 5
229910052921 ammonium sulfate Inorganic materials 0.000 description 5
239000001166 ammonium sulphate Substances 0.000 description 5
235000011130 ammonium sulphate Nutrition 0.000 description 5
235000013681 dietary sucrose Nutrition 0.000 description 5
229940079919 digestives enzyme preparation Drugs 0.000 description 5
239000012535 impurity Substances 0.000 description 5
238000012545 processing Methods 0.000 description 5
229960004793 sucrose Drugs 0.000 description 5
101710152845 Arabinogalactan endo-beta-1,4-galactanase Proteins 0.000 description 4
241000194108 Bacillus licheniformis Species 0.000 description 4
101710147028 Endo-beta-1,4-galactanase Proteins 0.000 description 4
241000588748 Klebsiella Species 0.000 description 4
238000005481 NMR spectroscopy Methods 0.000 description 4
230000000875 corresponding effect Effects 0.000 description 4
238000009630 liquid culture Methods 0.000 description 4
108010009355 microbial metalloproteinases Proteins 0.000 description 4
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
239000010452 phosphate Substances 0.000 description 4
229920000642 polymer Polymers 0.000 description 4
230000001376 precipitating effect Effects 0.000 description 4
150000003839 salts Chemical class 0.000 description 4
238000000527 sonication Methods 0.000 description 4
150000008163 sugars Chemical class 0.000 description 4
238000000108 ultra-filtration Methods 0.000 description 4
BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 3
241001467578 Microbacterium Species 0.000 description 3
238000005903 acid hydrolysis reaction Methods 0.000 description 3
150000007513 acids Chemical class 0.000 description 3
230000009471 action Effects 0.000 description 3
229940041514 candida albicans extract Drugs 0.000 description 3
238000012512 characterization method Methods 0.000 description 3
239000000284 extract Substances 0.000 description 3
239000000706 filtrate Substances 0.000 description 3
238000004128 high performance liquid chromatography Methods 0.000 description 3
238000004191 hydrophobic interaction chromatography Methods 0.000 description 3
239000007788 liquid Substances 0.000 description 3
238000005259 measurement Methods 0.000 description 3
229910052757 nitrogen Inorganic materials 0.000 description 3
238000011020 pilot scale process Methods 0.000 description 3
238000001556 precipitation Methods 0.000 description 3
239000000047 product Substances 0.000 description 3
239000002994 raw material Substances 0.000 description 3
238000011160 research Methods 0.000 description 3
239000010865 sewage Substances 0.000 description 3
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
241000894007 species Species 0.000 description 3
239000012138 yeast extract Substances 0.000 description 3
238000005084 2D-nuclear magnetic resonance Methods 0.000 description 2
239000012619 Butyl Sepharose® Substances 0.000 description 2
241000192093 Deinococcus Species 0.000 description 2
XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 2
229920000761 Levan polysaccharide Polymers 0.000 description 2
238000013494 PH determination Methods 0.000 description 2
LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
238000005571 anion exchange chromatography Methods 0.000 description 2
230000000903 blocking effect Effects 0.000 description 2
238000009835 boiling Methods 0.000 description 2
239000007853 buffer solution Substances 0.000 description 2
230000007797 corrosion Effects 0.000 description 2
238000005260 corrosion Methods 0.000 description 2
230000006866 deterioration Effects 0.000 description 2
238000006911 enzymatic reaction Methods 0.000 description 2
238000000855 fermentation Methods 0.000 description 2
230000004151 fermentation Effects 0.000 description 2
239000006481 glucose medium Substances 0.000 description 2
230000006872 improvement Effects 0.000 description 2
238000011534 incubation Methods 0.000 description 2
229910010272 inorganic material Inorganic materials 0.000 description 2
238000009533 lab test Methods 0.000 description 2
239000000463 material Substances 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 2
150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
238000007747 plating Methods 0.000 description 2
239000013587 production medium Substances 0.000 description 2
239000013074 reference sample Substances 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
JNIQBPHJIAOMQU-FSIIMWSLSA-N (2s,3s,4s,5r)-2,3,4,5-tetrahydroxy-6-oxoheptanoic acid Chemical compound CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O JNIQBPHJIAOMQU-FSIIMWSLSA-N 0.000 description 1
HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 1
PFFIDZXUXFLSSR-UHFFFAOYSA-N 1-methyl-N-[2-(4-methylpentan-2-yl)-3-thienyl]-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound S1C=CC(NC(=O)C=2C(=NN(C)C=2)C(F)(F)F)=C1C(C)CC(C)C PFFIDZXUXFLSSR-UHFFFAOYSA-N 0.000 description 1
108020004465 16S ribosomal RNA Proteins 0.000 description 1
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
241000589291 Acinetobacter Species 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
241000892910 Aspergillus foetidus Species 0.000 description 1
241000193830 Bacillus <bacterium> Species 0.000 description 1
241000193749 Bacillus coagulans Species 0.000 description 1
208000016444 Benign adult familial myoclonic epilepsy Diseases 0.000 description 1
241000588807 Bordetella Species 0.000 description 1
241000186146 Brevibacterium Species 0.000 description 1
241000589513 Burkholderia cepacia Species 0.000 description 1
101100188862 Caenorhabditis elegans osg-1 gene Proteins 0.000 description 1
229920003043 Cellulose fiber Polymers 0.000 description 1
240000001817 Cereus hexagonus Species 0.000 description 1
229920002271 DEAE-Sepharose Polymers 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
101000993376 Homo sapiens Hypermethylated in cancer 2 protein Proteins 0.000 description 1
241000216643 Hydrogenophaga Species 0.000 description 1
102100031612 Hypermethylated in cancer 1 protein Human genes 0.000 description 1
101710133850 Hypermethylated in cancer 1 protein Proteins 0.000 description 1
102100031613 Hypermethylated in cancer 2 protein Human genes 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
229920006063 Lamide® Polymers 0.000 description 1
241000193386 Lysinibacillus sphaericus Species 0.000 description 1
241000589323 Methylobacterium Species 0.000 description 1
241000212299 Microbulbifer Species 0.000 description 1
241000520272 Pantoea Species 0.000 description 1
241000588912 Pantoea agglomerans Species 0.000 description 1
239000001888 Peptone Substances 0.000 description 1
108010080698 Peptones Proteins 0.000 description 1
241000589516 Pseudomonas Species 0.000 description 1
241000232299 Ralstonia Species 0.000 description 1
241000589625 Ralstonia pickettii Species 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
239000005708 Sodium hypochlorite Substances 0.000 description 1
241000191940 Staphylococcus Species 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
229910000831 Steel Inorganic materials 0.000 description 1
101710172711 Structural protein Proteins 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
229920002522 Wood fibre Polymers 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
150000001241 acetals Chemical group 0.000 description 1
239000008186 active pharmaceutical agent Substances 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
238000013019 agitation Methods 0.000 description 1
229940072056 alginate Drugs 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
239000003957 anion exchange resin Substances 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
238000003556 assay Methods 0.000 description 1
229940054340 bacillus coagulans Drugs 0.000 description 1
230000032770 biofilm formation Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
239000005018 casein Substances 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000011210 chromatographic step Methods 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
238000004737 colorimetric analysis Methods 0.000 description 1
238000012505 colouration Methods 0.000 description 1
239000013065 commercial product Substances 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
239000013256 coordination polymer Substances 0.000 description 1
238000005100 correlation spectroscopy Methods 0.000 description 1
230000008021 deposition Effects 0.000 description 1
239000003599 detergent Substances 0.000 description 1
229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
238000010828 elution Methods 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
238000001952 enzyme assay Methods 0.000 description 1
238000001317 epifluorescence microscopy Methods 0.000 description 1
239000006167 equilibration buffer Substances 0.000 description 1
208000016427 familial adult myoclonic epilepsy Diseases 0.000 description 1
235000019387 fatty acid methyl ester Nutrition 0.000 description 1
239000000835 fiber Substances 0.000 description 1
239000012467 final product Substances 0.000 description 1
ZGNITFSDLCMLGI-UHFFFAOYSA-N flubendiamide Chemical compound CC1=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C1NC(=O)C1=CC=CC(I)=C1C(=O)NC(C)(C)CS(C)(=O)=O ZGNITFSDLCMLGI-UHFFFAOYSA-N 0.000 description 1
239000012530 fluid Substances 0.000 description 1
235000013305 food Nutrition 0.000 description 1
239000012737 fresh medium Substances 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
238000003929 heteronuclear multiple quantum coherence Methods 0.000 description 1
238000000990 heteronuclear single quantum coherence spectrum Methods 0.000 description 1
150000004677 hydrates Chemical class 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
239000008235 industrial water Substances 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
150000002484 inorganic compounds Chemical class 0.000 description 1
239000011147 inorganic material Substances 0.000 description 1
230000003993 interaction Effects 0.000 description 1
238000011835 investigation Methods 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
239000008101 lactose Substances 0.000 description 1
150000002605 large molecules Chemical class 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
150000002704 mannoses Chemical class 0.000 description 1
238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
239000012528 membrane Substances 0.000 description 1
BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
230000002906 microbiologic effect Effects 0.000 description 1
238000011169 microbiological contamination Methods 0.000 description 1
238000009629 microbiological culture Methods 0.000 description 1
125000000896 monocarboxylic acid group Chemical group 0.000 description 1
230000035772 mutation Effects 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
235000021049 nutrient content Nutrition 0.000 description 1
239000005022 packaging material Substances 0.000 description 1
235000019319 peptone Nutrition 0.000 description 1
231100000614 poison Toxicity 0.000 description 1
230000007096 poisonous effect Effects 0.000 description 1
239000008057 potassium phosphate buffer Substances 0.000 description 1
238000007639 printing Methods 0.000 description 1
239000006041 probiotic Substances 0.000 description 1
235000018291 probiotics Nutrition 0.000 description 1
238000001742 protein purification Methods 0.000 description 1
238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
229940107700 pyruvic acid Drugs 0.000 description 1
238000004064 recycling Methods 0.000 description 1
239000004576 sand Substances 0.000 description 1
230000007017 scission Effects 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000008107 starch Substances 0.000 description 1
239000010959 steel Substances 0.000 description 1
239000010902 straw Substances 0.000 description 1
238000012916 structural analysis Methods 0.000 description 1
239000001117 sulphuric acid Substances 0.000 description 1
235000011149 sulphuric acid Nutrition 0.000 description 1
239000000725 suspension Substances 0.000 description 1
235000019640 taste Nutrition 0.000 description 1
238000001551 total correlation spectroscopy Methods 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
238000012546 transfer Methods 0.000 description 1
238000011179 visual inspection Methods 0.000 description 1
239000002023 wood Substances 0.000 description 1
229920001221 xylan Polymers 0.000 description 1
150000004823 xylans Chemical class 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F3/00—Biological treatment of water, waste water, or sewage
- C02F3/34—Biological treatment of water, waste water, or sewage characterised by the microorganisms used
- C02F3/342—Biological treatment of water, waste water, or sewage characterised by the microorganisms used characterised by the enzymes used
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38636—Preparations containing enzymes, e.g. protease or amylase containing enzymes other than protease, amylase, lipase, cellulase, oxidase or reductase
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01089—Arabinogalactan endo-beta-1,4-galactanase (3.2.1.89)

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Microbiology (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
General Chemical & Material Sciences (AREA)
Biotechnology (AREA)
Hydrology & Water Resources (AREA)
Water Supply & Treatment (AREA)
Oil, Petroleum & Natural Gas (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Environmental & Geological Engineering (AREA)
Biodiversity & Conservation Biology (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Enzymes And Modification Thereof (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

CA002385300A 1999-09-29 2000-09-29 A method for treating biofilm and other slime products with endo-beta-1,2-galactanase Abandoned CA2385300A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FI19992095		1999-09-29
FI992095A FI109921B (fi)	1999-09-29	1999-09-29	Menetelmä ja entsyymivalmiste prosessiteollisuuteen
PCT/FI2000/000842 WO2001023534A1 (en)	1999-09-29	2000-09-29	A method for treating biofilm and other slime products with endo-beta-1,2-galactanase

Publications (1)

Publication Number	Publication Date
CA2385300A1 true CA2385300A1 (en)	2001-04-05

Family

ID=8555378

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002385300A Abandoned CA2385300A1 (en)	1999-09-29	2000-09-29	A method for treating biofilm and other slime products with endo-beta-1,2-galactanase

Country Status (8)

Country	Link
EP (1)	EP1224269A1 (fi)
AU (1)	AU7424400A (fi)
BR (1)	BR0014375A (fi)
CA (1)	CA2385300A1 (fi)
FI (1)	FI109921B (fi)
NZ (1)	NZ518380A (fi)
WO (1)	WO2001023534A1 (fi)
ZA (1)	ZA200202840B (fi)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN106414698A (zh) *	2014-06-04	2017-02-15	诺维信公司	洗涤剂组合物

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPS328002A0 (en)	2002-06-28	2002-07-18	Novapharm Research (Australia) Pty Ltd	Water treatment
CN100546178C (zh) *	2003-12-19	2009-09-30	宇部兴产株式会社	制造压电薄膜器件的方法和压电薄膜器件
BRPI0811809A8 (pt) *	2007-06-28	2017-04-04	Dow Brasil Sudeste Ind Ltda	Método para produzir um produto baseado em fermentação e método para produzir etanol
WO2009001205A2 (en) *	2007-06-28	2008-12-31	Dow Brasil Sudeste Industrial Ltda.	Methods to control bacterial growth in fermentation processes
WO2009028481A1 (ja) *	2007-08-28	2009-03-05	Diamond Engineering Co., Ltd.	活性汚泥資材、生物反応槽内の余剰汚泥の減量方法、及び生物反応槽の維持管理方法
CN102943052B (zh) *	2012-11-22	2014-02-05	台州职业技术学院	一株耐重金属的多环芳烃降解菌及其在复合污染土壤修复中的应用
US10081783B2 (en)	2016-06-09	2018-09-25	The Procter & Gamble Company	Cleaning compositions having an enzyme system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH09117297A (ja) *	1995-10-26	1997-05-06	Meiji Milk Prod Co Ltd	ガラクトオリゴ糖の製造方法
US5985593A (en) *	1996-10-11	1999-11-16	Integrated Research Technology, L.L.C.	Compositions and methods for enzymatic decontamination
US6100080A (en) *	1996-12-18	2000-08-08	Novo Nordisk A/S	Method for enzymatic treatment of biofilm
EP0896998A1 (en) *	1997-08-14	1999-02-17	The Procter & Gamble Company	Laundry detergent compositions comprising a saccharide gum degrading enzyme

1999
- 1999-09-29 FI FI992095A patent/FI109921B/fi not_active IP Right Cessation
2000
- 2000-09-29 WO PCT/FI2000/000842 patent/WO2001023534A1/en active IP Right Grant
- 2000-09-29 AU AU74244/00A patent/AU7424400A/en not_active Abandoned
- 2000-09-29 BR BR0014375-8A patent/BR0014375A/pt not_active IP Right Cessation
- 2000-09-29 NZ NZ518380A patent/NZ518380A/en unknown
- 2000-09-29 CA CA002385300A patent/CA2385300A1/en not_active Abandoned
- 2000-09-29 EP EP00962568A patent/EP1224269A1/en not_active Withdrawn
2002
- 2002-04-11 ZA ZA200202840A patent/ZA200202840B/xx unknown

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN106414698A (zh) *	2014-06-04	2017-02-15	诺维信公司	洗涤剂组合物
US10647947B2 (en)	2014-06-04	2020-05-12	Novozymes A/S	Detergent composition

Also Published As

Publication number	Publication date
EP1224269A1 (en)	2002-07-24
ZA200202840B (en)	2003-01-29
FI19992095A (fi)	2001-03-29
AU7424400A (en)	2001-04-30
BR0014375A (pt)	2002-06-18
FI109921B (fi)	2002-10-31
NZ518380A (en)	2003-09-26
WO2001023534A1 (en)	2001-04-05

Publication	Publication Date	Title
Elad et al.	1999	The role of Trichoderma harzianum protease in the biocontrol of Botrytis cinerea
An et al.	2009	Alginate‐deriving oligosaccharide production by alginase from newly isolated Flavobacterium sp. LXA and its potential application in protection against pathogens
US5231022A (en)	1993-07-27	Cellulase isolated from bacillus ferm bp-3431 or a mutant strain thereof
Verma et al.	2012	Isolation and production of cellulase enzyme from bacteria isolated from agricultural fields in district Hardoi, Uttar Pradesh, India
JP3605414B2 (ja)	2004-12-22	糖化合物
JPS6336775A (ja)	1988-02-17	β―マンナナーゼおよびβ―マンノシダーゼ生産能を有するアルカリ性バチルス属新菌株
Tenkanen et al.	1995	An acetylglucomannan esterase of Aspergillus oryzae; purification, characterization and role in the hydrolysis of O-acetyl-galactoglucomannan
Esawy et al.	2012	Characterization of extracellular dextranase from a novel halophilic Bacillus subtilis NRC-B233b a mutagenic honey isolate under solid state fermentation
CA2385300A1 (en)	2001-04-05	A method for treating biofilm and other slime products with endo-beta-1,2-galactanase
EP0006035B1 (en)	1982-07-07	Bacterial beta-galactosidase, immobilized forms thereof, process for their preparation and use in the hydrolysis of lactose, and novel bacteria
DE69008194T2 (de)	1994-07-28	Aus einem nocardiopsis-stamm stammendes bakteriolytisches enzym, seine herstellung und verwendung.
JP3917258B2 (ja)	2007-05-23	新規アルカリペクチン酸リアーゼ及びその製造法
Bicho et al.	1991	The characterisation of a thermostable endo-β-1, 4-mannanase cloned from “Caldocellum saccharolyticum”
Singh et al.	2017	Cellulolytic activity in microorganisms
Abe et al.	1994	Isolation of β-mannanase-producing microorganism
US5702605A (en)	1997-12-30	Slime hydrolase producing bacterium and process for producing slime hydrolase
JP4556344B2 (ja)	2010-10-06	新規ヘキセンウロニダーゼ、それをコードする遺伝子、およびそれらの使用
Moid et al.	2021	Development of xylanase as detergent additive to improve laundry application
JP5685398B2 (ja)	2015-03-18	ポリガラクツロナーゼ
JP3332510B2 (ja)	2002-10-07	洗浄剤組成物
JP3002140B2 (ja)	2000-01-24	新規なキチナーゼとその製造法
FALAHAT et al.	2007	Production and purification of a protease from an alkalophilic Bacillus sp. 2-5 strain isolated from soil
JPH07107971A (ja)	1995-04-25	アルカリに安定なサイクロデキストリングルカノトランスフェラーゼ及びその製造法
JP4382953B2 (ja)	2009-12-16	ポリガラクツロナーゼ
JP4139537B2 (ja)	2008-08-27	ポリガラクツロナーゼ

Legal Events

Date	Code	Title	Description
2005-09-29	FZDE	Dead